ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Aligned Fibronectin Microenvironment Temporally Facilitates Profibrotic Fibroblast Activation via Integrin α5β1.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Excessive, aligned nanofibrous extracellular matrix deposition is a main feature of fibrosis, a pathology indicative of poor prognosis in various chronic diseases. Fibronectin is one of the major nanofibrous extracellular matrix proteins that contribute to tissue homeostasis and repair via its cell surface receptors, integrins. Although mechanosensing of aligned fibronectin by fibroblasts is also implicated in the initiation and progression of fibrogenesis, the mechanisms involved remain uncertain. To investigate how profibrotic cell responses and fibrotic tissue development are triggered through these interactions in vitro, we utilized fibroblasts expressing fibronectin-binding integrins (αV-class and α5β1 integrins) cultured on fibronectin-coated electrospun nanofibers with random or aligned networks. During early adhesion, fibroblasts employ a specific integrin, α5β1 integrin, to respond to the aligned nanofibrous fibronectin microenvironment by strengthening cell and F-actin alignments, nascent focal adhesion, and alpha-smooth muscle actin expression that are signatures of early pro-fibrotic activities. Interestingly, α5β1 integrin-mediated fibronectin alignment sensing continues to form fibrotic tissues at a later stage associated with higher alignment, greater alpha-smooth muscle actin expression, and extensive extracellular matrix deposition. This mechanistic insight paves the way to better understand the role of fibronectin and its properties in pathophysiology, representing a new target for potential applications in drug discovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.